Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MBRX | AMGN | VRTX | GILD | BMY |
| Company | Moleculin Biotech CS | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.7100 | 276.97 | 422.73 | 92.01 | 56.00 |
| High | 1.9279 | 276.97 | 428.25 | 92.80 | 56.62 |
| Low | 1.7100 | 269.78 | 419.27 | 91.68 | 55.55 |
| Last | 1.8800 | 272.11 | 422.00 | 91.84 | 56.29 |
| Change | +0.1400 | +2.68 | +5.04 | +0.19 | -0.09 |
| % Change | +8.05% | +0.99% | +1.21% | +0.21% | -0.16% |
| Volume | 45,200 | 3,244,200 | 1,773,500 | 6,862,200 | 10,911,600 |
| 20-Day Average Volume | 62,235 | 3,507,620 | 2,097,760 | 6,621,070 | 10,784,580 |
| Previous Close | 1.7400 | 269.43 | 416.96 | 91.65 | 56.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.7665 | 263.65 | 410.50 | 91.78 | 56.68 |
| 20-Day Raw Stochastic | 63.33% | 79.47% | 47.37% | 54.68% | 39.63% |
| 20-Day Relative Strength | 45.84% | 48.46% | 45.68% | 51.97% | 48.76% |
| Weighted Alpha | -68.12 | -14.36 | -7.30 | +15.35 | +17.59 |
| Today's Opinion | 88% Sell | 88% Sell | 72% Sell | 56% Buy | 40% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 72% Sell | 40% Buy | 40% Buy |
| Last Month's Opinion | 56% Sell | 88% Sell | 24% Sell | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.63% since 01/10/25 | +3.77% since 01/10/25 | +3.04% since 01/10/25 | +2.18% since 01/10/25 | +0.82% since 01/10/25 |
| Low | 1.6000 on 01/13/25 | 261.28 on 01/13/25 | 397.24 on 01/13/25 | 89.02 on 01/13/25 | 54.81 on 01/13/25 |
| High | 1.9900 on 01/14/25 | 276.97 on 01/17/25 | 428.25 on 01/17/25 | 93.07 on 01/16/25 | 56.74 on 01/15/25 |
| 1-Month | |||||
| %Chg | +1.08% since 12/17/24 | +2.32% since 12/17/24 | -10.07% since 12/17/24 | -1.03% since 12/17/24 | -2.36% since 12/17/24 |
| Low | 1.5000 on 12/23/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 88.57 on 01/10/25 | 54.81 on 01/13/25 |
| High | 2.1000 on 12/18/24 | 276.97 on 01/17/25 | 471.05 on 12/18/24 | 94.55 on 12/26/24 | 58.54 on 12/18/24 |
| 3-Month | |||||
| %Chg | -20.34% since 10/17/24 | -15.32% since 10/17/24 | -15.39% since 10/17/24 | +5.13% since 10/17/24 | +5.85% since 10/17/24 |
| Low | 1.5000 on 12/23/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 85.60 on 10/22/24 | 51.81 on 10/28/24 |
| High | 3.3300 on 11/14/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | -57.61% since 07/17/24 | -18.94% since 07/17/24 | -13.59% since 07/17/24 | +25.29% since 07/17/24 | +30.45% since 07/17/24 |
| Low | 1.5000 on 12/23/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 70.78 on 07/23/24 | 41.60 on 07/19/24 |
| High | 4.7070 on 07/18/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,999 | 146,268,096 | 108,677,232 | 114,457,056 | 114,166,088 |
| Shares Outstanding, K | 3,191 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -29,770,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -10,590,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 1.94 | 0.56 | 0.40 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.09 on 11/08/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/08/24 | 02/04/25 | 02/03/25 | 02/11/25 | 02/06/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 12/13/24 | 0.620 on 01/03/25 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 12/13/24 | 01/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.02 | 0.00 | 20.69 | 48.19 |